# Dose-Ranging Study of the Bimatoprost Ocular Insert

> **NCT02358369** · PHASE2 · COMPLETED · sponsor: **ForSight Vision5, Inc.** · enrollment: 156 (actual)

## Conditions studied

- Primary Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost
- **DRUG:** Timolol 0.5%
- **DEVICE:** Placebo Ocular Insert
- **DRUG:** Placebo Eye Drops

## Key facts

- **NCT ID:** NCT02358369
- **Lead sponsor:** ForSight Vision5, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-19
- **Primary completion:** 2015-08-31
- **Final completion:** 2015-10-07
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02358369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02358369, "Dose-Ranging Study of the Bimatoprost Ocular Insert". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02358369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*